Clinical Trial: Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.

U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07320781) titled 'Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.' on Dec. 21, 2025.

Brief Summary: This study evaluated the preemptive analgesic efficacy of Tapentadol in reducing peri operative analgesic requirements among patients undergoing breast cancer surgery.

Study Start Date: Nov. 15, 2024

Study Type: INTERVENTIONAL

Condition: Postoperative Pain in Patients of Breast Cancer Surgery

Intervention: DRUG: Tapentadol

75 mg oral tapentadol given 1 hour before surgery in control group and placebo tablet was given in Group B. Intraoperative and post opera...